全文获取类型
收费全文 | 7091篇 |
免费 | 398篇 |
国内免费 | 29篇 |
专业分类
耳鼻咽喉 | 31篇 |
儿科学 | 191篇 |
妇产科学 | 138篇 |
基础医学 | 870篇 |
口腔科学 | 133篇 |
临床医学 | 455篇 |
内科学 | 1951篇 |
皮肤病学 | 272篇 |
神经病学 | 404篇 |
特种医学 | 227篇 |
外科学 | 1265篇 |
综合类 | 16篇 |
预防医学 | 178篇 |
眼科学 | 193篇 |
药学 | 359篇 |
中国医学 | 3篇 |
肿瘤学 | 832篇 |
出版年
2023年 | 61篇 |
2022年 | 120篇 |
2021年 | 194篇 |
2020年 | 81篇 |
2019年 | 120篇 |
2018年 | 156篇 |
2017年 | 129篇 |
2016年 | 177篇 |
2015年 | 182篇 |
2014年 | 213篇 |
2013年 | 258篇 |
2012年 | 446篇 |
2011年 | 475篇 |
2010年 | 241篇 |
2009年 | 233篇 |
2008年 | 432篇 |
2007年 | 417篇 |
2006年 | 476篇 |
2005年 | 412篇 |
2004年 | 430篇 |
2003年 | 438篇 |
2002年 | 421篇 |
2001年 | 121篇 |
2000年 | 97篇 |
1999年 | 102篇 |
1998年 | 105篇 |
1997年 | 90篇 |
1996年 | 76篇 |
1995年 | 57篇 |
1994年 | 69篇 |
1993年 | 59篇 |
1992年 | 55篇 |
1991年 | 79篇 |
1990年 | 69篇 |
1989年 | 55篇 |
1988年 | 58篇 |
1987年 | 34篇 |
1986年 | 32篇 |
1985年 | 22篇 |
1984年 | 25篇 |
1983年 | 22篇 |
1982年 | 19篇 |
1981年 | 18篇 |
1980年 | 11篇 |
1979年 | 17篇 |
1978年 | 10篇 |
1974年 | 10篇 |
1973年 | 12篇 |
1972年 | 12篇 |
1971年 | 9篇 |
排序方式: 共有7518条查询结果,搜索用时 15 毫秒
41.
Shohei Nakamura Yutaka Kobayashi Kazuhiko Tozuka Akihiko Tokue Akira Kimura Chikuma Hamada 《The Journal of urology》1996,156(4):1275-1279
Purpose
Circadian changes in urinary frequency, diuresis and bladder capacity were evaluated in middle-aged and elderly patients.Materials and Methods
A total of 2,703 urinations from 50 men (median age 66 years) was recorded with a 24-hour uroflowmetry system.Results
During a 24-hour period the elderly group showed increased frequency and decreased bladder capacity. No difference was observed in diuresis between the 2 age groups. From midnight to 6 a.m. frequency in the elderly group was significantly greater (p less than 0.01) than that in the middle-aged group.Conclusions
Increased frequency in the elderly group during these hours was primarily due to an increase in diuresis. 相似文献42.
Yoshikazu Noguchi Tatsuo Makino Takaki Yoshikawa Katsutoshi Nomura Kuniyasu Fukuzawa Akihiko Matsumoto Takuko Yamada 《Surgery today》1996,26(1):36-41
This study was conducted to investigate the role of tumor necrosis factor- (TNF-) and interleukin-2 (IL-2) in inducing cancer cachexia, and the results were compared with those obtained from our previous study on Fisher 344 rats with methylcholanthrene-induced sarcoma. Three groups of male Fisher 344 rats received one of the following regimens: 4×104 IU of human recombinant TNF- per rat per day subcutaneously (sc) for 5 consecutive days (n=5), 3.5×105 U human recombinant IL-2 per rat per day sc for 14 consecutive days (n=5), or normal saline (n=5). The activities of both phosphoenolpyruvate carboxykinase (PEPCK) and malic enzyme (ME) were increased slightly in the IL-2 group. Furthermore, LPL activity was significantly increased in the adipose tissue of the TNF group and in the cardiac muscle of the IL-2 group, but not in that of the TNF group. These results show that there is a significant difference between the metabolic alterations seen in the tumor-bearing state and those induced by either TNF- or IL-2 alone. Thus, it is unlikely that IL-2 or TNF- is the sole mediator of cancer cachexia in this tumor and rat model. 相似文献
43.
A 45-year-old male presented with spontaneous dissecting aneurysm in the anterior cerebral artery manifesting as headache persisting for several days and speech disturbance. Neurological and laboratory examinations showed no abnormalities. Magnetic resonance imaging revealed infarction in the right cingulate gyrus. Angiography revealed occlusion of the right A2. Repeat angiography 8 months later showed a saccular aneurysm had developed. The interhemispheric approach exposed the aneurysm at the junction between the right frontopolar artery and the pericallosal artery. The aneurysm was fusiform due to the right A2 dissection. The aneurysm was trapped and resected. One month after the operation, the patient was discharged without neurological deficits. Cases of dissecting aneurysms in the anterior cerebral artery with ischemic onset are usually treated conservatively. Cases requiring surgery include those due to trauma, growing aneurysms, giant aneurysms, and uncontrolled hypertension. Some dissecting aneurysms of the distal anterior cerebral artery require only resection without bypass surgery. 相似文献
44.
Hideaki Suzuki Akira Shimomura Katsuhisa Ikeda Masayuki Furukawa Takeshi Oshima Tomonori Takasaka 《The Laryngoscope》1997,107(12):1661-1666
The mechanism of macrolide therapy in chronic sinusitis patients is unclear. The authors studied the effect of macrolides on interleukin (IL)-8 secretion from cultured human nasal epithelial cells. Epithelial cells harvested from the nasal polyps of patients with chronic sinusitis were primary-cultured, and secreted IL-8 in culture media was measured by enzyme immunoassay. The cells secreted considerable amounts of IL-8 constitutively and in response to lipopolysaccharide. The secretion was significantly inhibited by 10?5 M of erythromycin, clarithromycin, roxithromycin, and josamycin. 10?6 M erythromycin still showed the inhibitory effect, whereas the same concentration of josamycin did not. These results indicate that macrolide antibiotics may act as an immunomodulator to reduce IL-8 in inflammatory sites and, at least partially, account for the clinically discrepant effects between 14- and 16-membered ring macrolides in long-term low-dose therapy for chronic sinusitis. 相似文献
45.
Y Naoe M Inami S Matsumoto S Takagaki T Fujiwara S Yamazaki I Kawamura F Nishigaki S Tsujimoto T Manda K Shimomura 《Japanese journal of cancer research》1998,89(12):1306-1317
The antitumor effects of FK317, a novel substituted dihydrobenzoxazine, were evaluated using human tumor xenografts (small cell lung cancer, non-small cell lung cancer, stomach cancer, colon cancer, pancreatic cancer, breast cancer, cervical cancer and ovarian cancer). Tumor growth-inhibitory effects and the effective dose-range of FK317 were much stronger and broader, respectively, than those of reference drugs such as mitomycin C, adriamycin, cisplatin, taxol and irinotecan. Furthermore, the body weight decrease and myelosuppression in FK317-treated mice were less than in the animals given any of the reference drugs. To explain this tumor selectivity, the distribution of FK317 was investigated after dosing tumor-bearing mice with the 14C-labelled compound. The concentration of FK317 in tumor tissues was relatively low, and long tumor retention was not observed. However, thin-layer chromatographic separation revealed that the radioactivity in the tumor resided mainly in strongly cytotoxic metabolites, while that in other tissues resided mainly in non-cytotoxic metabolites. These results suggest that FK317 shows strong antitumor activity without side effects, and one reason for this is its specific metabolite pattern. FK317 is now undergoing phase I clinical trials. 相似文献
46.
Y Naoe I Kawamura M Inami S Matsumoto F Nishigaki S Tsujimoto T Manda K Shimomura 《Japanese journal of cancer research》1998,89(12):1318-1325
The effects of FK317 (11-acetyl-8-carbamoyloxymethyl-4-formyl-6- methoxy-14-oxa-1,11-diazatetracyclo[7.4.1.0(2, 7). 0(10, 2] tetradeca-2,4,6-trien-9-yl acetate), a novel anti-cancer agent, on murine adenocarcinoma colon26- and human lung carcinoma LX-1-induced cachexia were investigated in mice. Mice bearing colon26 or LX-1 s.c. lost weight and became cachectic, associated with tumor growth. FK317 and mitomycin C (MMC) inhibited the growth of both tumors. FK317 ameliorated the weight loss induced by the presence of colon26 or LX-1, while MMC enhanced it. An attenuation of the reduction in the weights of epididymal fat, gastrocnemius muscle and carcass was observed in FK317-treated tumor-bearing mice in both cachexia models, but not in MMC-treated mice. The decreases in the circulating levels of triglyceride, glucose and non-esterified fatty acid, which were induced by the presence of colon26, was partially inhibited by treatment with FK317. Overall, this study revealed that FK317 is a potent anti-cancer drug with anti-cachectic activity, suggesting that FK317 has potential utility for the treatment of cancer. 相似文献
47.
Yoshinori Naoe Masamichi Inami Ikuo Kawamura Fusako Nishigaki Susumu Tsujimoto Sanae Matsumoto Toshitaka Manda Kyoichi Shimomura 《Cancer science》1998,89(6):666-672
FK317 is a member of a new class of bioreductive agents that exhibit strong cytotoxicity against various human cancer cells. The effect of FK317 was found to be stronger than that of mitomycin C (MMC), adriamycin (ADR) or cisplatin (CDDP). Alkaline elution analysis indicated that FK317 formed interstrand DNA-DNA and DNA-protein cross-links in cells. On the other hand, no DNA single-strand breaks were observed in the cells treated with FK317. In a cell-free system the deacetylated metabolites produced cross-linked DNA under reductive conditions, though FK317 itself did not form DNA-DNA cross-links. In order to elucidate the metabolic activation mechanisms, we established an FK317-resistant subline from human non-small cell lung cancer cells (Lu99) by stepwise and brief exposure (1 h) to FK317. The resistant subline (Lu99/317) showed cross-resistance to MMC and carboquone (CQ), but not to ADR or CDDP. DT-diaphorase, which is one of the activation enzymes of MMC and CQ, was deficient in Lu99/317 cells as determined by enzyme activity assay. However, the levels of NADPH:cytochrome P450 reductase, which is another activation enzyme for MMC and CQ, were comparable in resistant and parent cell lines. Treatment of the cells with dicumarol, an inhibitor of DT-diaphorase, reduced the cytotoxicity of FK317 to Lu99 cells, but not to Lu99/317 cells. These results indicate that deacetylation of FK317 is necessary for its reductive activation, and deacetylated FK317 is reduced by DT-diaphorase to form an active metabolite, which produces DNA-DNA interstrand and DNA-protein cross-links that lead to cell death. 相似文献
48.
Lower rate of preeclampsia after antioxidant supplementation in pregnant women with low antioxidant status. 总被引:11,自引:0,他引:11
Dewi Rumiris Yuditiya Purwosunu Noroyono Wibowo Antonio Farina Akihiko Sekizawa 《Hypertension in pregnancy》2006,25(3):241-253
OBJECTIVE: To investigate maternal and neonatal outcomes after antioxidant supplementation relatively early in pregnancy (8 to 12 weeks) for pregnant women with low antioxidant status. METHODS: A randomized, double-blind, placebo-controlled trial of daily antioxidant supplementation was performed on pregnant women screening positive for low antioxidant status at 8 to 12 weeks of gestation. Low antioxidant status was defined as a superoxidedismutase (SOD) level below 1102 U/g Hb or 164 U/mL. The supplementation group received the following antioxidants daily: vitamins A (1000 IU), B6 (2.2 mg), B12 (2.2 microg), C (200 mg), and E (400 IU), folic acid (400 microg), N-acetylcysteine (200 mg), Cu (2 mg), Zn (15 mg), Mn (0.5 mg), Fe (30 mg), calcium (800 mg), and selenium (100 microg). The control group received Fe (30 mg) and folic acid (400 microg). Maternal (preeclampsia, abortion, and hypertension) and perinatal outcomes were assessed. RESULTS: In the supplementation group (29 subjects), we observed 2 cases of preeclampsia (6.8%, 1 mild and 1 severe), 1 of IUGR (birth weight 2300 g at 38 weeks), and 1 preterm delivery. In the control group (31 subjects), there were 8 abortions, 9 cases of preeclampsia (29%, 6 mild and 3 severe) with perinatal outcome: 3 preterm delivery cases and 1 IUGR (birth weight 2030 g at 39 weeks). Preeclampsia was significantly less frequent in the supplementation group when compared to the control group (2 vs. 9 cases, p = 0.043, OR = 0.18 [95% CI: 0.03, 0.92]). Finally we focused on the prediction of preeclampsia at 8 to 12 weeks. Combined sensitivity of markers of antioxidant status (SOD slutathione peroxidase, [GPx], and total anti-oxidant status [TAS]) was 33% (false-positive rate of 4.5%). CONCLUSION: Antioxidant supplementation was associated with better maternal and perinatal outcome in pregnant women with low antioxidant status than control supplementation with iron and folate alone. In a selected population already screened positive for low SOD, preeclampsia can be detected in 33% of asymptomatic cases in the first trimester using SOD, GPx, and TAS. It seems feasible that panels of both biochemical and molecular markers may be clinically useful in the prediction of this disease. 相似文献
49.
Long-lasting renal dysfunction following tacrolimus induction therapy in ulcerative colitis patients
Na Cha Naoki Oshima Kenichi Kishimoto Satoshi Kotani Eiko Okimoto Tomotaka Yazaki Hiroki Sonoyama Akihiko Oka Yoshiyuki Mishima Kotaro Shibagaki Hiroshi Tobita Kousaku Kawashima Norihisa Ishimura Shunji Ishihara 《Journal of Clinical Biochemistry and Nutrition》2022,70(3):297
Although tacrolimus (TAC) has remarkable effects in ulcerative colitis (UC) patients when given as remission induction therapy, some can develop renal dysfunction during TAC administration, resulting in withdrawal, though related details remain poorly understood. This study was conducted to determine the impact of oral TAC on renal function for remission induction therapy in UC patients. Fifty-five patients (10 elderly, 45 non-elderly) with UC and treated with oral TAC at our hospital were retrospectively evaluated. Renal function was assessed using estimated glomerular filtration rate (eGFR). Although a high clinical response to TAC was seen in both elderly and non-elderly, a decline in eGFR was noted in nearly all patients regardless of age, with a maximum change of −34.4% from the baseline value at week 11. Furthermore, eGFR decline recovered quickly after TAC discontinuation, though did not return to the baseline at two years following cessation. The rate of eGFR change at week 12 was significantly associated with patient age (β = −0.3242, p = 0.0103) and peak serum trough level during TAC treatment (β = 0.3563, p = 0.0051). Furthermore, the rate of decline in eGFR was significantly greater during treatment with TAC in the elderly as compared to non-elderly, with a large difference in eGFR decline rate between those groups also noted at two years after withdrawal of treatment. Careful attention to renal function when administering oral TAC for UC is important and changes in eGFR should be monitored closely in elderly patients even after treatment cessation. 相似文献
50.
We herein describe a 68‐year‐old man with follicular mucinosis. A dermoscopic examination showed multiple, round, brownish yellow dots with a whitish rim in the follicular ostium and red dots in the interfollicular area. This case report is the first to suggest that follicular mucinosis shows these dermoscopic findings. 相似文献